Published • loading... • Updated
A new Rutgers study links GLP-1 drugs like Ozempic and Wegovy to a weaker connection between impulsivity, drinking and violence — though researchers say it's far from proof.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
A new Rutgers study links GLP-1 drugs like Ozempic and Wegovy to a weaker connection between impulsivity, drinking and violence — though researchers say it's far from proof.
A Rutgers University study found GLP-1 drugs such as Ozempic and Wegovy were linked to a weaker connection between impulsivity, alcohol use and violent behavior, but researchers stress the observational findings don't prove cause and effect.
GLP-1 agonists are demonstrating effects that go far beyond the control of diabetes and obesity. New research in the United States suggests that these treatments, popularly known for their ability to favor weight loss and treat diabetes, could also lessen the relationship between impulsivity, alcohol consumption and violent behaviors. Although more studies and a greater volume of scientific evidence are still needed, the findings open up a new l…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
